Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 27


A targeted 3D EM and correlative microscopy method using SEM array tomography.

Burel A, Lavault MT, Chevalier C, Gnaegi H, Prigent S, Mucciolo A, Dutertre S, Humbel BM, Guillaudeux T, Kolotuev I.

Development. 2018 Jun 21;145(12). pii: dev160879. doi: 10.1242/dev.160879.


Discovery of Human-Similar Gene Fusions in Canine Cancers.

Ulvé R, Rault M, Bahin M, Lagoutte L, Abadie J, De Brito C, Coindre JM, Botherel N, Rousseau A, Wucher V, Cadieu E, Thieblemont C, Hitte C, Cornevin L, Cabillic F, Bachelot L, Gilot D, Hennuy B, Guillaudeux T, Le Goff A, Derrien T, Hédan B, André C.

Cancer Res. 2017 Nov 1;77(21):5721-5727. doi: 10.1158/0008-5472.CAN-16-2691. Epub 2017 Sep 7.


Mechanisms of action and structure-activity relationships of cytotoxic flavokawain derivatives.

Thieury C, Lebouvier N, Le Guével R, Barguil Y, Herbette G, Antheaume C, Hnawia E, Asakawa Y, Nour M, Guillaudeux T.

Bioorg Med Chem. 2017 Mar 15;25(6):1817-1829. doi: 10.1016/j.bmc.2017.01.049. Epub 2017 Feb 6.


Role of the tumor microenvironment in regulating apoptosis and cancer progression.

Yaacoub K, Pedeux R, Tarte K, Guillaudeux T.

Cancer Lett. 2016 Aug 10;378(2):150-9. doi: 10.1016/j.canlet.2016.05.012. Epub 2016 May 17. Review.


Lectin-like transcript 1 is a marker of germinal center-derived B-cell non-Hodgkin's lymphomas dampening natural killer cell functions.

Germain C, Guillaudeux T, Galsgaard ED, Hervouet C, Tekaya N, Gallouet AS, Fassy J, Bihl F, Poupon G, Lazzari A, Spee P, Anjuère F, Pangault C, Tarte K, Tas P, Xerri L, Braud VM.

Oncoimmunology. 2015 Apr 8;4(8):e1026503. eCollection 2015 Aug.


COX-2-independent effects of celecoxib sensitize lymphoma B cells to TRAIL-mediated apoptosis.

Gallouet AS, Travert M, Bresson-Bepoldin L, Guilloton F, Pangault C, Caulet-Maugendre S, Lamy T, Tarte K, Guillaudeux T.

Clin Cancer Res. 2014 May 15;20(10):2663-73. doi: 10.1158/1078-0432.CCR-13-2305. Epub 2014 Mar 17.


Quercetin-mediated Mcl-1 and survivin downregulation restores TRAIL-induced apoptosis in non-Hodgkin's lymphoma B cells.

Jacquemin G, Granci V, Gallouet AS, Lalaoui N, Morlé A, Iessi E, Morizot A, Garrido C, Guillaudeux T, Micheau O.

Haematologica. 2012 Jan;97(1):38-46. doi: 10.3324/haematol.2011.046466. Epub 2011 Sep 20.


CD40 ligand protects from TRAIL-induced apoptosis in follicular lymphomas through NF-kappaB activation and up-regulation of c-FLIP and Bcl-xL.

Travert M, Ame-Thomas P, Pangault C, Morizot A, Micheau O, Semana G, Lamy T, Fest T, Tarte K, Guillaudeux T.

J Immunol. 2008 Jul 15;181(2):1001-11.


Human mesenchymal stem cells isolated from bone marrow and lymphoid organs support tumor B-cell growth: role of stromal cells in follicular lymphoma pathogenesis.

Amé-Thomas P, Maby-El Hajjami H, Monvoisin C, Jean R, Monnier D, Caulet-Maugendre S, Guillaudeux T, Lamy T, Fest T, Tarte K.

Blood. 2007 Jan 15;109(2):693-702. Epub 2006 Sep 19.


Sensitivity of prostate cells to TRAIL-induced apoptosis increases with tumor progression: DR5 and caspase 8 are key players.

Hesry V, Piquet-Pellorce C, Travert M, Donaghy L, Jégou B, Patard JJ, Guillaudeux T.

Prostate. 2006 Jun 15;66(9):987-95.


[Clinical applications of TRAIL in cancers. The prostate cancer example].

Hesry V, Guillaudeux T, Patard JJ.

Pathol Biol (Paris). 2003 Apr;51(3):123-8. Review. French. No abstract available.


The making of "transgenic spermatozoa".

Celebi C, Guillaudeux T, Auvray P, Vallet-Erdtmann V, Jégou B.

Biol Reprod. 2003 May;68(5):1477-83. Epub 2002 Dec 27. Review.


Transient transmission of a transgene in mouse offspring following in vivo transfection of male germ cells.

Celebi C, Auvray P, Benvegnu T, Plusquellec D, Jégou B, Guillaudeux T.

Mol Reprod Dev. 2002 Aug;62(4):477-82.


Characterization of a novel testicular form of human hormone-sensitive lipase.

Mairal A, Melaine N, Laurell H, Grober J, Holst LS, Guillaudeux T, Holm C, Jégou B, Langin D.

Biochem Biophys Res Commun. 2002 Feb 22;291(2):286-90.


Testis hormone-sensitive lipase expression in spermatids is governed by a short promoter in transgenic mice.

Blaise R, Guillaudeux T, Tavernier G, Daegelen D, Evrard B, Mairal A, Holm C, Jégou B, Langin D.

J Biol Chem. 2001 Feb 16;276(7):5109-15. Epub 2000 Nov 13.


The complete genomic sequence of 424,015 bp at the centromeric end of the HLA class I region: gene content and polymorphism.

Guillaudeux T, Janer M, Wong GK, Spies T, Geraghty DE.

Proc Natl Acad Sci U S A. 1998 Aug 4;95(16):9494-9.


HLA-G transcription studies during the different stages of normal and malignant hematopoiesis.

Amiot L, Onno M, Renard I, Drénou B, Guillaudeux T, Le Bouteiller P, Fauchet R.

Tissue Antigens. 1996 Nov;48(5):609-14.


Expression of HLA class I genes in meiotic and post-meiotic human spermatogenic cells.

Guillaudeux T, Gomez E, Onno M, Drénou B, Segretain D, Alberti S, Lejeune H, Fauchet R, Jégou B, Le Bouteiller P.

Biol Reprod. 1996 Jul;55(1):99-110.


HLA-G transcription studies during the different stages of normal and malignant hematopoiesis.

Amiot L, Onno M, Renard I, Drénou B, Guillaudeux T, Le Bouteiller P, Fauchet R.

Tissue Antigens. 1996 May;47(5):408-13. Corrected and republished in: Tissue Antigens. 1996 Nov;48(5):609-14.


Placental expression of HLA class I genes.

Le Bouteiller P, Rodriguez AM, Mallet V, Girr M, Guillaudeux T, Lenfant F.

Am J Reprod Immunol. 1996 Mar;35(3):216-25. Review.


Supplemental Content

Loading ...
Support Center